Inherited Metabolic Diseases in Adult Age


JIM 2025; 2 (3): e1003
DOI: 10.61012_20258_1003

Potential applications of digital health technologies in adults with inherited metabolic disorders

JIM 2025; 2 (Suppl 1): e958
DOI: 10.61012_20256_958

Adult phenylketonuria: transition management and follow-up

JIM 2025; 2 (2): e922
DOI: 10.61012_20255_922

Primary lipid myopathies: a narrative review

JIM 2025; 2 (1): e709
DOI: 10.61012_20252_709

Genotype and phenotype of subjects with Tangier disease developing cardiovascular disease

JIM 2025; 2 (1): e707
DOI: 10.61012_20252_707

Changes in the care of patients with lysosomal storage diseases in the post-COVID-19 era

JIM 2024; 1 (4): e632
DOI: 10.61012_202411_632

Hereditary fructose intolerance in adults: from differential diagnosis to long-term management. A report from the Florence cohort

JIM 2024; 1 (2): e537
DOI: 10.61012_20245_537

Supportive care in adults with Fabry disease: low-cost interventions for high-value achievements

JIM 2024; 1 (1): e460
DOI: 10.61012_20242_460

Rhabdomyolysis in clinical practice